Full Press Release Details
Sagimet Biosciences to Participate in the UBS Global Healthcare Conference.
SGMT
Sagimet Biosciences to Participate in the UBS Global Healthcare Conference
Key Takeaway: Sagimet Biosciences to Participate in the UBS Global Healthcare Conference
Price reaction · baseline $6 (2024-11-06 close) · hit after-hours · 1 other SGMT headline(s) in the window, move may be shared
day 0 close · peak
+3.2%
Conference Participation Details
UBS Global Healthcare Conference
Date: November 11, 2025
Time: 8:45 a.m. ET
Format: Fireside Chat
How to Access
Investors and the general public can listen to both sessions live at:
https://investor.viatris.comArchived versions will be available following the live events for a limited time.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+110%
120-day peak, hindsight
Typical move
5.7%
average across 12 past catalysts
Cash runway
~69 mo
Minimal dilution risk
Lead asset
TVB-2640
Phase 2 · Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease